6 Results from a systematic review and meta-analysis study showed that following discontinuation of weight management medications: Patients are estimated to return to baseline weight within 1.7 years 1,** Results from that same study also highlighted that following discontinuation of weight management medications: Cardiometabolic benefits may be lost, with markers estimated to return to baseline within 1.4 years 1,** Ongoing obesity treatment is needed for maintaining weight loss and improvements in cardiometabolic markers 4 Addressing Discontinuation Starts With Understanding What May Influence Adherence and Persistence 5 Long-term adherence is shaped by multiple, interconnected factorsand ongoing research continues to explore how challenges may interact over time
As a doctor, I can tell you that we dont believe in a one-size-fits-all approach
Whether youre comparing Wegovy to comprehensive programs or evaluating different medical weight loss options, focus on programs that offer: Proven results with realistic timelines based on clinical data Medical supervision to optimize your treatment and manage any challenges Comprehensive support beyond just medication Transparent pricing without hidden costs or insurance complications Why The Data Matters The difference between 6% and 13% weight loss in your first 12 weeks isnt just about numbersits about momentum, confidence, and reaching your goals in a timeframe that keeps you motivated throughout your journey
PMID: 16987039 | DOI: 10.1089/ars.2006.8.1865 [2] Erden-Inal M, Sunal E, Kanbak G
Walk-ins welcome no appointment needed